Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

7,144 results
MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 3
1967 3
1968 2
1969 4
1970 3
1971 2
1972 5
1973 3
1974 4
1975 2
1976 5
1977 8
1978 6
1979 17
1980 11
1981 10
1982 23
1983 34
1984 29
1985 45
1986 47
1987 50
1988 59
1989 59
1990 70
1991 57
1992 85
1993 62
1994 90
1995 91
1996 87
1997 62
1998 86
1999 87
2000 82
2001 105
2002 129
2003 149
2004 187
2005 190
2006 198
2007 221
2008 288
2009 325
2010 368
2011 337
2012 456
2013 515
2014 592
2015 738
2016 616
2017 530
2018 618
2019 307
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

7,144 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Cancer Cell Dormancy
Recasens A and Munoz L. Trends Pharmacol Sci 2019 - Review. PMID 30612715
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Gluz O, et al. J Clin Oncol 2016 - Clinical Trial. PMID 26926676
PURPOSE: The 21-gene Recurrence Score (RS) assay is a validated prognostic/predictive tool in early hormone receptor-positive breast cancer (BC); however, only a few prospective outcome results have been available so far. ...Nodal status, central and local grade, the Ki-67 protein encoded by the MKI67 gene, estrogen receptor, progesterone receptor, tumor size, and RS were univariate prognostic factors for disease-free survival; only nodal status, both central and local grade, and RS were independent multivariate factors. ...
PURPOSE: The 21-gene Recurrence Score (RS) assay is a validated prognostic/predictive tool in early hormone receptor-positive breast cancer (BC); however, only a few prospective outcome results have been available so far. ...Nodal status, central and local grade, the Ki-67 protein enco …
Cancer of the corpus uteri
Amant F, et al. Int J Gynaecol Obstet 2018. PMID 30306580
Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal. Treatment tailored to tumor biology is the optimal strategy to balance treatment efficacy against toxicity. ...
Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal. Treatment tailored to tumor biology is the optimal strategy to balance treatment efficacy against toxicity. ...
Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
Osterman E and Glimelius B. Dis Colon Rectum 2018. PMID 30086050
OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern staging, surgery, and pathology have been implemented. ...CONCLUSIONS: The recurrence rate is less than that previously observed in historical materials, but current, commonly used risk factors are still useful in evaluating recurrence risks. ...
OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern staging, surgery, and pathology have been implemented. ...CONCLUSIONS: The recurrence rate is less than that previously observed in historical materials, but current, commonly used risk …
Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
Dürr HR, et al. BMC Cancer 2018. PMID 29558901 Free PMC article.
Patients were followed for evidence of local recurrence or distant metastasis. Overall and recurrence-free survival was calculated. ...Nine patient died in follow-up, 4 of them with metastatic disease, all nonpulmonary. 5-year local recurrence (LR) free survival was 82%. 4 (9.3%) patients developed LR (all R1). ...
Patients were followed for evidence of local recurrence or distant metastasis. Overall and recurrence-free survival was calculated. ...Nine patient died in follow-up, 4 of them with metastatic disease, all nonpulmonary. 5-year local recurrence (LR) free survival wa …
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Broglio KR, et al. JAMA Oncol 2016. PMID 26914222
CONCLUSIONS AND RELEVANCE: Pathologic complete response in HER2-positive breast cancer is associated with substantially longer times to recurrence and death. ...
CONCLUSIONS AND RELEVANCE: Pathologic complete response in HER2-positive breast cancer is associated with substantially longer times to recurrence and death. ...
Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
Song B, et al. Pathol Int 2018. PMID 30094896
In this study, we aimed to determine whether the microscopic extension into surrounding normal tissue can influence the local recurrence of MFS and UPS. ...The length of 5.5 mm was selected as the optimal cut-off value that could predict local recurrence using the receiver operating characteristic (ROC) curve and Youden index. ...
In this study, we aimed to determine whether the microscopic extension into surrounding normal tissue can influence the local recurrence of MFS and UPS. ...The length of 5.5 mm was selected as the optimal cut-off value that could predict local recurrence using the receive …
Lipoblastoma: a clinicopathologic review of 23 cases from a major tertiary care center plus detailed review of literature
Abdul-Ghafar J, et al. BMC Res Notes 2018 - Review. PMID 29343278 Free PMC article.
OBJECTIVE: Lipoblastoma is a rare neoplasm that occurs mostly in infants and children. Although benign, it has a tendency for local recurrence. ...Owing to a high recurrence rate following incomplete resection, a complete resection is essential. Prognosis is excellent after complete resection....
OBJECTIVE: Lipoblastoma is a rare neoplasm that occurs mostly in infants and children. Although benign, it has a tendency for local recurrence. ...Owing to a high recurrence rate following incomplete resection, a complete resection is essential. Prognosis is excellent aft …
Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy.
Saleh T, et al. Cancer Res 2019. PMID 30803994
Consequently, we propose that senescence represents one avenue whereby tumor cells evade the direct cytotoxic impact of therapy, thereby allowing for prolonged survival in a dormant state, with the potential to recover self-renewal capacity and contribute to disease recurrence....
Consequently, we propose that senescence represents one avenue whereby tumor cells evade the direct cytotoxic impact of therapy, thereby allowing for prolonged survival in a dormant state, with the potential to recover self-renewal capacity and contribute to disease recurrence....
High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.
Willeumier J, et al. Int Orthop 2015. PMID 25743028
Tumour size proved a consistent adverse prognostic factor for local recurrence (hazard ratio (HR) 3.9), distant metastasis (HR 4.9) and overall survival (HR 2.4). ...The occurrence of local recurrence had a significant impact on overall survival (HR 2.0). CONCLUSIONS: The results of this study confirm the critical role of tumour size on survival and margins on local recurrence, and stress the need for further investigation concerning the association between margins, local recurrence and survival....
Tumour size proved a consistent adverse prognostic factor for local recurrence (hazard ratio (HR) 3.9), distant metastasis (HR 4.9) and overall survival (HR 2.4). ...The occurrence of local recurrence had a significant impact on overall survival (HR 2.0). CONCLUSIONS: The …
7,144 results
Jump to page
Feedback